Oral GLP-1 Candidate Aleniglipron Posts Weight Loss Data Rivaling Wegovy Pill in Phase II Trial
Structure Therapeutics recently shared new results from its latest obesity study. The data shows that their oral drug, aleniglipron,…
-
-
Advances in Drug Therapy and GLP-1 Receptor Agonists: Emerging Treatments Reshaping Modern Medicine
The world of medicine is currently moving through a very busy and exciting time. New ways of treating diseases…
-
Eli Lilly’s Orforglipron Positions to Challenge Novo Nordisk’s Oral GLP-1 Lead
Eli Lilly is preparing to launch a new weight-loss pill called orforglipron. They expect the government to approve it…
-
Evidence Backed Ways to Restart Your GLP-1 Weight Loss Progress
Glucagon-like peptide-1 medications have changed how we treat weight issues. These powerful drugs help many people lose a lot…
-
Public Speculation Over Oprah Winfrey’s Appearance Reignites Debate on GLP-1 Weight Loss Medications
A public figure’s noticeably slimmer look at a recent event created a lot of talk online. Many people on…
-
From Ozempic to Oral Pills: The New Breakthrough in Weight Loss Medicine
GLP-1 drugs have changed the conversation around weight loss and blood sugar control in the US, but most of…
-
FDA Approves Oral Semaglutide for Weight Loss, Cheaper Alternative to Injectable GLP-1 Drugs
In January 2026, the U.S. Food and Drug Administration approved an oral formulation of semaglutide for weight management. This…
-
Novo Nordisk to Slash GLP-1 List Prices by Up to 50% in U.S. to Cut Costs for Insured Patients
Novo Nordisk recently confirmed a major shift in its pricing strategy for GLP-1 receptor agonist medications. The manufacturer plans…
-
Oral GLP-1 Pill Orforglipron Posts Strong Phase 3 Results in Adults With Type 2 Diabetes
Eli Lilly recently shared excellent news about a novel medication. The company tested the investigational drug orforglipron in extensive…
-
Oral Semaglutide Found Cost-Saving Over Dulaglutide for Type 2 Diabetes in Taiwan, Study Shows
A new economic analysis finds that oral semaglutide may save money and improve outcomes for patients with type 2…
